Cochrane Abstracts
Palliative cytoreductive surgery versus other palliative treatments in patients with unresectable liver metastases from gastro‐entero‐pancreatic neuroendocrine tumours New
Palliative cytoreductive surgery versus other palliative treatments in patients with unresectable liver metastases from gastro‐entero‐pancreatic neuroendocrine tumours New is a topic covered in the Cochrane Abstracts.
To view the entire topic, please sign in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this entry is available only to subscribers.
Citation
"Palliative Cytoreductive Surgery Versus Other Palliative Treatments in Patients With Unresectable Liver Metastases From Gastro‐entero‐pancreatic Neuroendocrine Tumours New." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434544/all/Palliative_cytoreductive_surgery_versus_other_palliative_treatments_in_patients_with_unresectable_liver_metastases_from_gastro‐entero‐pancreatic_neuroendocrine_tumours_New. Accessed 01 October 2020.
Palliative cytoreductive surgery versus other palliative treatments in patients with unresectable liver metastases from gastro‐entero‐pancreatic neuroendocrine tumours New. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434544/all/Palliative_cytoreductive_surgery_versus_other_palliative_treatments_in_patients_with_unresectable_liver_metastases_from_gastro‐entero‐pancreatic_neuroendocrine_tumours_New. Accessed October 1, 2020.
Palliative cytoreductive surgery versus other palliative treatments in patients with unresectable liver metastases from gastro‐entero‐pancreatic neuroendocrine tumours New. In Cochrane Abstracts Retrieved October 01, 2020, from https://evidence.unboundmedicine.com/evidence/view/Cochrane/434544/all/Palliative_cytoreductive_surgery_versus_other_palliative_treatments_in_patients_with_unresectable_liver_metastases_from_gastro‐entero‐pancreatic_neuroendocrine_tumours_New
Palliative Cytoreductive Surgery Versus Other Palliative Treatments in Patients With Unresectable Liver Metastases From Gastro‐entero‐pancreatic Neuroendocrine Tumours New [Internet]. In: Cochrane Abstracts. [cited 2020 October 01]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434544/all/Palliative_cytoreductive_surgery_versus_other_palliative_treatments_in_patients_with_unresectable_liver_metastases_from_gastro‐entero‐pancreatic_neuroendocrine_tumours_New.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Palliative cytoreductive surgery versus other palliative treatments in patients with unresectable liver metastases from gastro‐entero‐pancreatic neuroendocrine tumours New
ID - 434544
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434544/all/Palliative_cytoreductive_surgery_versus_other_palliative_treatments_in_patients_with_unresectable_liver_metastases_from_gastro‐entero‐pancreatic_neuroendocrine_tumours_New
DB - Evidence Central
DP - Unbound Medicine
ER -
